Profil
William Fisher is the founder of Accurate Venture, Inc. He currently holds the positions of President & Chief Executive Officer at Golden Grail Merger Corp.
and Chairman, CEO & Chief Strategist at Leaf Vertical, Inc. Previously, he served as Chief Executive Officer & Director at Golden Grail Technology Corp.
Postes actifs de Bill Fisher
| Sociétés | Poste | Début |
|---|---|---|
Golden Grail Merger Corp.
Golden Grail Merger Corp. Financial ConglomeratesFinance Provides investment services | Directeur Général | - |
Leaf Vertical, Inc.
Leaf Vertical, Inc. Leaf Vertical, Inc. operates as clinical-stage biopharmaceutical research company, engages in discovering and developing novel therapeutics from its proprietary cannabinoid product platform. It offers BRCX, a new drug delivering a specific dose of a proprietary formula for the treatment of colon cancer. The company is headquartered in Orlando, FL. | Directeur Général | - |
Anciens postes connus de Bill Fisher
| Sociétés | Poste | Fin |
|---|---|---|
| GOLDEN GRAIL TECHNOLOGY CORP. | Directeur Général | 07/12/2017 |
Accurate Venture, Inc.
Accurate Venture, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Golden Grail Technology Corp.
Golden Grail Technology Corp. Beverages: Non-AlcoholicConsumer Non-Durables Manufactures and sells beverages | Consumer Non-Durables |
Accurate Venture, Inc.
Accurate Venture, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Golden Grail Merger Corp.
Golden Grail Merger Corp. Financial ConglomeratesFinance Provides investment services | Finance |
Leaf Vertical, Inc.
Leaf Vertical, Inc. Leaf Vertical, Inc. operates as clinical-stage biopharmaceutical research company, engages in discovering and developing novel therapeutics from its proprietary cannabinoid product platform. It offers BRCX, a new drug delivering a specific dose of a proprietary formula for the treatment of colon cancer. The company is headquartered in Orlando, FL. |
















